|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of Shizuoka |
|---|---|
| Collaborator: |
Maruyama Memorial General Hospital |
| Information provided by: | University of Shizuoka |
| ClinicalTrials.gov Identifier: | NCT00309426 |
Purpose
The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.
| Condition |
|---|
|
Hemodialysis Malnutrition |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study |
| Official Title: | The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients |
| Estimated Enrollment: | 300 |
| Study Start Date: | March 2001 |
| Estimated Study Completion Date: | March 2006 |
Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.
Eligibility| Ages Eligible for Study: | up to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Japan, Shizuoka | |
| Maruyama Hospital | |
| Hamamatsu, Shizuoka, Japan, 430-0001 | |
| Study Chair: | Hiromichi Kumagai, MD | University of Shizuoka |
More Information
| Study ID Numbers: | CT2006003 |
| Study First Received: | March 27, 2006 |
| Last Updated: | May 18, 2006 |
| ClinicalTrials.gov Identifier: | NCT00309426 History of Changes |
| Health Authority: | Japan: Ministry of Health, Labor and Welfare |
|
atherosclerosis |
|
Malnutrition Nutrition Disorders |